Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Medica Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 164.50.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Medica Group. This rating has held steady since August 2022, when it changed from a Buy consensus rating.
Medica Group Plc, together with its subsidiaries, provides teleradiology reporting services to NHS trusts, private hospital groups, and diagnostic imaging companies in the United Kingdom, Ireland, and the United States. It offers NightHawk, an out-of-hours service, which provides emergency reporting services through radiologists for stroke and major trauma; cardiac, computerized tomography (CT) colonography, PET CT and nuclear medicine, CT Cone Beam, DEXA, audit, and MR prostate services; AI powered CT Brain solution for detection of intracranial haemorrhage to acute teleradiology reporting workflow; and elective scanning services. The company also provides routine plain film and radiographer plain film services, and managed services, as well as ophthalmology services and various imaging lab services. Medica Group Plc was founded in 2004 and is headquartered in Hastings, the United Kingdom.